Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.13 USD | +2.40% | +15.76% | -28.76% |
Mar. 25 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
Mar. 25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.76% | 403M | |
+25.61% | 660B | |
+22.86% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+12.45% | 219B | |
-9.69% | 196B | |
+6.39% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.
- Esperion Therapeutics in Disagreement With Partner Over Cholesterol Drug Milestone Payments; Shares Fall Pre-Bell